Elucidating the precise pharmacological mechanism of action (MOA) of Normally developing compounds is often complicated. Even though Tarselli et al. (60) formulated the 1st de novo artificial pathway to conolidine and showcased that this By natural means occurring compound successfully suppresses responses to the two chemically induced and inflamma